Abstract
Bronchopulmonary dysplasia (BPD) is a common cause of chronic lung disease in infants born prematurely (<37 weeks gestation) and is associated with high morbidity, particularly during the first 2 years of life. The diagnosis of BPD is given to preterm infants who require supplemental oxygen for at least the first 28 days of life. Infants who are diagnosed with severe BPD have an oxygen requirement of greater than 30 % and/or the need for positive pressure ventilation at 36 weeks post-conceptual age or at discharge. Infants with severe BPD are most likely to have persistent respiratory failure requiring home invasive ventilation. Risk of death in children on home mechanical ventilation is high despite current monitoring technology.
BPD is formally defined on the basis of anoxygen requirement at specific post-conceptual time points, but this measure does not capture the spectrum of respiratory phenotypes that encompass BPD. Infants and children may have varying combinations of parenchymal, vascular, small airway and large airway disease. The protean manifestations of BPD frequently require tailoring and frequent assessment of ventilator management and other respiratory care on the individual level. The strategies used to ventilate a child in chronic respiratory failure with BPD will likely need to be modulated based on the presenting combination of respiratory phenotypes.
This chapter covers the epidemiology of BPD and those who require long-term ventilation as well manifestations of disease, strategies for ventilation as well as weaning ventilation, the use of polysomnography, decannulation strategies, equipment needs, and comorbidities. Although the heterogeneity of lung disease and its various components of parenchymal, vascular, small airway and large airway disease make it challenging to manage, infants with BPD can be ventilated in the home setting effectively. Successful ventilation is dependent on caregiver training, appropriate resources, and availability of subspecialty care. Unlike many other pediatric respiratory diseases that may require home invasive ventilation, infants and children with BPD have a higher likelihood of being weaned from support with good lung growth.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Greenough A. Long-term pulmonary outcome in the preterm infant. Neonatology. 2008;93(4):324–7.
Jobe AH, Bancalari E. Bronchopulmonary dysplasia. Am J Respir Crit Care Med. 2001;163(7):1723–9.
Laughon MM, Langer JC, Bose CL, Smith PB, Ambalavanan N, Kennedy KA, et al. Prediction of bronchopulmonary dysplasia by postnatal age in extremely premature infants. Am J Respir Crit Care Med. 2011;183(12):1715–22. Pubmed Central PMCID: 3136997.
Hamilton BE, Hoyert DL, Martin JA, Strobino DM, Guyer B. Annual summary of vital statistics: 2010-2011. Pediatrics. 2013;131(3):548–58.
Sidman JD, Jaguan A, Couser RJ. Tracheotomy and decannulation rates in a level 3 neonatal intensive care unit: a 12-year study. Laryngoscope. 2006;116(1):136–9.
Sisk EA, Kim TB, Schumacher R, Dechert R, Driver L, Ramsey AM, et al. Tracheotomy in very low birth weight neonates: indications and outcomes. Laryngoscope. 2006;116(6):928–33.
Cristea AI, Carroll AE, Davis SD, Swigonski NL, Ackerman VL. Outcomes of children with severe bronchopulmonary dysplasia who were ventilator dependent at home. Pediatrics. 2013;132(3):e727–34. Pubmed Central PMCID: 3876749.
Joseph RA. Tracheostomy in infants: parent education for home care. Neonatal Network. 2011;30(4):231–42.
Boroughs D, Dougherty JA. Decreasing accidental mortality of ventilator-dependent children at home: a call to action. Home Healthc Nurse. 2012;30(2):103–11; quiz 12–3.
Edwards JD, Kun SS, Keens TG. Outcomes and causes of death in children on home mechanical ventilation via tracheostomy: an institutional and literature review. J Pediatr. 2010;157(6):955–9. e2.
Thurlbeck WM. Postnatal human lung growth. Thorax. 1982;37(8):564–71. Pubmed Central PMCID: 459376.
Frank L, Sosenko IR. Undernutrition as a major contributing factor in the pathogenesis of bronchopulmonary dysplasia. Am Rev Respir Dis. 1988;138(3):725–9.
Lefton-Greif MA, McGrath-Morrow SA. Deglutition and respiration: development, coordination, and practical implications. Semin Speech Lang. 2007;28(3):166–79.
Thebaud B, Abman SH. Bronchopulmonary dysplasia: where have all the vessels gone? Roles of angiogenic growth factors in chronic lung disease. Am J Respir Crit Care Med. 2007;175(10):978–85. Pubmed Central PMCID: 2176086.
Hadchouel A, Franco-Montoya ML, Delacourt C. Altered lung development in bronchopulmonary dysplasia. Birth Defects Res A Clin Mol Teratol. 2014;100(3):158–67.
Abman SH. Impaired vascular endothelial growth factor signaling in the pathogenesis of neonatal pulmonary vascular disease. Adv Exp Med Biol. 2010;661:323–35.
Mourani PM, Abman SH. Pulmonary vascular disease in bronchopulmonary dysplasia: pulmonary hypertension and beyond. Curr Opin Pediatr. 2013;25(3):329–37.
Collaco JM, Romer LH, Stuart BD, Coulson JD, Everett AD, Lawson EE, et al. Frontiers in pulmonary hypertension in infants and children with bronchopulmonary dysplasia. Pediatr Pulmonol. 2012;47(11):1042–53. Pubmed Central PMCID: 3963167.
Farquhar M, Fitzgerald DA. Pulmonary hypertension in chronic neonatal lung disease. Paediatr Respir Rev. 2010;11(3):149–53.
Carmosino MJ, Friesen RH, Doran A, Ivy DD. Perioperative complications in children with pulmonary hypertension undergoing noncardiac surgery or cardiac catheterization. Anesth Analg. 2007;104(3):521–7. Pubmed Central PMCID: 1934984.
Kim GB. Pulmonary hypertension in infants with bronchopulmonary dysplasia. Korean J Pediatr. 2010;53(6):688–93. Pubmed Central PMCID: 2994133.
Abman SH et al. Pediatric pulmonary hypertension: Guidelines from the American Heart Association and American Thoracic Society. Circulation. 2015 Nov 24;132(21):2037–99.
Mourani P, Mullen M, Abman SH. Pulmonary hypertension in bronchopulmonary dysplasia. Prog Pediatr Cardiol. 2009;27(1–2):43–8.
Abman SH. Monitoring cardiovascular function in infants with chronic lung disease of prematurity. Arch Dis Child Fetal Neonatal Ed. 2002;87(1):F15–8. Pubmed Central PMCID: 1721426.
Dhillon R. The management of neonatal pulmonary hypertension. Arch Dis Child Fetal Neonatal Ed. 2012;97(3):F223–8.
Khemani E, McElhinney DB, Rhein L, Andrade O, Lacro RV, Thomas KC, et al. Pulmonary artery hypertension in formerly premature infants with bronchopulmonary dysplasia: clinical features and outcomes in the surfactant era. Pediatrics. 2007;120(6):1260–9.
Vrijlandt EJ, Gerritsen J, Boezen HM, Grevink RG, Duiverman EJ. Lung function and exercise capacity in young adults born prematurely. Am J Respir Crit Care Med. 2006;173(8):890–6.
Landry JS, Chan T, Lands L, Menzies D. Long-term impact of bronchopulmonary dysplasia on pulmonary function. Canad Respir J. 2011;18(5):265–70. Pubmed Central PMCID: 3267603.
Wright CJ, Kirpalani H. Targeting inflammation to prevent bronchopulmonary dysplasia: can new insights be translated into therapies? Pediatrics. 2011;128(1):111–26. Pubmed Central PMCID: 3124103.
Doyle LW, Ehrenkranz RA, Halliday HL. Postnatal hydrocortisone for preventing or treating bronchopulmonary dysplasia in preterm infants: a systematic review. Neonatology. 2010;98(2):111–7.
Onland W, Offringa M, van Kaam A. Late (>/= 7 days) inhalation corticosteroids to reduce bronchopulmonary dysplasia in preterm infants. Cochrane Database Syst Rev. 2012;4, CD002311.
ad hoc Statement Committee ATS. Mechanisms and limits of induced postnatal lung growth. Am J Respir Crit Care Med. 2004;170(3):319–43.
Baraldi E, Filippone M. Chronic lung disease after premature birth. N Engl J Med. 2007;357(19):1946–55.
Sterni LM et al. An official American Thoracic Society clinical practice guideline: Pediatric chronic home invasive ventilation. Am J Respir Crit Care Med. 2016 Apr 15;193(8):e16–35.
Lee KS, Sun MR, Ernst A, Feller-Kopman D, Majid A, Boiselle PM. Comparison of dynamic expiratory CT with bronchoscopy for diagnosing airway malacia: a pilot evaluation. Chest. 2007;131(3):758–64.
Kim DH, Kim HS, Choi CW, Kim EK, Kim BI, Choi JH. Risk factors for pulmonary artery hypertension in preterm infants with moderate or severe bronchopulmonary dysplasia. Neonatology. 2012;101(1):40–6.
An HS, Bae EJ, Kim GB, Kwon BS, Beak JS, Kim EK, et al. Pulmonary hypertension in preterm infants with bronchopulmonary dysplasia. Korean Circ J. 2010;40(3):131–6. Pubmed Central PMCID: 2844979.
Slaughter JL, Pakrashi T, Jones DE, South AP, Shah TA. Echocardiographic detection of pulmonary hypertension in extremely low birth weight infants with bronchopulmonary dysplasia requiring prolonged positive pressure ventilation. J Perinatol. 2011;31(10):635–40.
Bhat R, Salas AA, Foster C, Carlo WA, Ambalavanan N. Prospective analysis of pulmonary hypertension in extremely low birth weight infants. Pediatrics. 2012;129(3):e682–9. Pubmed Central PMCID: 3289526.
Kumar VH, Hutchison AA, Lakshminrusimha S, Morin 3rd FC, Wynn RJ, Ryan RM. Characteristics of pulmonary hypertension in preterm neonates. J Perinatol. 2007;27(4):214–9.
Sharma PB, Baroody F, Gozal D, Lester LA. Obstructive sleep apnea in the formerly preterm infant: an overlooked diagnosis. Front Neurol. 2011;2:73. Pubmed Central PMCID: 3226060.
Graham RJ, Fleegler EW, Robinson WM. Chronic ventilator need in the community: a 2005 pediatric census of Massachusetts. Pediatrics. 2007;119(6):e1280–7.
Sakashita K, Matthews WJ, Yamamoto LG. Disaster preparedness for technology and electricity-dependent children and youth with special health care needs. Clin Pediatr. 2013;52(6):549–56.
Kun SS, Davidson-Ward SL, Hulse LM, Keens TG. How much do primary care givers know about tracheostomy and home ventilator emergency care? Pediatr Pulmonol. 2010;45(3):270–4.
Kun SS, Edwards JD, Ward SL, Keens TG. Hospital readmissions for newly discharged pediatric home mechanical ventilation patients. Pediatr Pulmonol. 2012;47(4):409–14. Pubmed Central PMCID: 3694986.
Panitch HB. Viral respiratory infections in children with technology dependence and neuromuscular disorders. Pediatr Infect Dis J. 2004;23(11 Suppl):S222–7.
Chidekel AS, Rosen CL, Bazzy AR. Rhinovirus infection associated with serious lower respiratory illness in patients with bronchopulmonary dysplasia. Pediatr Infect Dis J. 1997;16(1):43–7.
American Academy of Pediatrics Committee on Infectious Diseases, American Academy of Pediatrics Bronchiolitis Guidelines C. Updated guidance for palivizumab prophylaxis among infants and young children at increased risk of hospitalization for respiratory syncytial virus infection. Pediatrics. 2014;134(2):415–20.
Hsu KK, Shea KM, Stevenson AE, Pelton SI, Members of the Massachusetts Department of Public H. Underlying conditions in children with invasive pneumococcal disease in the conjugate vaccine era. Pediatr Infect Dis J. 2011;30(3):251–3.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer Science+Business Media New York
About this chapter
Cite this chapter
McGrath-Morrow, S.A., Collaco, J.M. (2016). Long-Term Ventilator Support in Bronchopulmonary Dysplasia. In: Sterni, L., Carroll, J. (eds) Caring for the Ventilator Dependent Child. Respiratory Medicine. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-3749-3_15
Download citation
DOI: https://doi.org/10.1007/978-1-4939-3749-3_15
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-3747-9
Online ISBN: 978-1-4939-3749-3
eBook Packages: MedicineMedicine (R0)